Mergerify.com | Strategic Acquisition: Growing Pharmaceutical Business Available

Project Detail

Strategic Acquisition: Growing Pharmaceutical Business Available

Expectation

TBD
  •    $ 30m
  •    18%
  •    Pharmaceuticals/Labs
  •    India
  •    N/A
  •    Andhra Pradesh
  •    Guntur
  •    2008
  •    200

Overview

Company Overview:
• Location: USFDA-approved facility (2023) based in Hyderabad
• Core Operations:
i. Own APIs & Intermediates (6 products, 3 currently commercialised)
ii. Contract Manufacturing (DMF-backed molecules)
iii. Collaborations with Innovators (Japanese & Korean partnerships for novel molecules)
• Revenue: ~₹208 crore in FY2024
• Profitability: Gross Margin ~35%; Net Margin 15–18% (from mature, high-performing products)
• Current Clients: EU, Korea


Share this page:

Similar Project

Our Achivments

Need Help?

We would be more than happy to help you. Our team advisor are 24/7 at your service to help you.

(+91) 8080 722 622
help@mergerify.com